Smoldering Alzheimer's disease (AD):
Pathology Beyond Amyloid Plaque

Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that starts well before clinical symptoms, and continues beyond amyloid plaque. It can best be described as a smoldering disease, similar to pathologies in several other chronic diseases. To learn more about the distinct amyloid species involved in AD, and the educational concept of smoldering AD, explore the following resources available to view, listen, or download.

Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that starts well before clinical symptoms, and continues beyond amyloid plaque. It can best be described as a smoldering disease, similar to pathologies in several other chronic diseases. To learn more about the distinct amyloid species involved in AD, and the educational concept of smoldering AD, explore the following resources available to view, listen, or download.

    Sort By

    Resources

    Content Type


    Apply Clear

Unfortunately, there are no results for this topic. Please modify your search.

Click Here to Go back

{{ promo.Title.slice(0, 160) }} Tooltip

{{ promo.Title }}

Title of the activity : {{ promo.Title }}

Provider : {{ promo.Provider }}

Virtual Enduring : {{ promo.VirtualEnduring }}

{{ promo.Title.slice(0, 160) }}

{{ promo.Title}}

{{ truncateText(promo.Title, promo.Description, 160) }}

Tooltip

{{ promo.Title }}

{{ promo.Description }}

{{ promo.AssetTag }}

COMING SOON

{{ promo.CTAText }}
Load More

Clinical Trials

Notepad

Clinical Trials

Eisai has numerous drug candidates in clinical development and is actively recruiting for trials in neurology.

Explore Clinical Trials

Grants

Support

Grants

This website provides policies and procedures for the preparation and submission of requests for Medical Education Grants (ME) and Investigator-Initiated Studies (IIS).

Explore Eisai Grants Process